DOMINIQUE POPE: Open Payments
NPI 1700591385 · ELLICOTT CITY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,226 in 50 payments from 14 companies in 2025. Trend: 2023 $243 · 2024 $1,091 · 2025 $1,226
Food & beverage: $1,226
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 7 | $248 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $165 |
| Vanda Pharmaceuticals Inc. | 4 | $119 |
| Lundbeck LLC | 5 | $116 |
| Alkermes, Inc. | 5 | $99 |
| Collegium Pharmaceutical, Inc. | 5 | $99 |
| Neurocrine BioSciences, Inc. | 3 | $90 |
| Supernus Pharmaceuticals, Inc. | 5 | $87 |
| Otsuka America Pharmaceutical, Inc. | 3 | $70 |
| ABBVIE INC. | 2 | $41 |
Products named: COBENFY, CAPLYTA, REXULTI, HETLIOZ, Jornay PM, INGREZZA, Qelbree, ARISTADA.
Industry payments across MD — which companies pay providers there.
